GlassScriptPhysician profile
Jonathan P Rodie
NPI 1215104633
$4,712.30
in general payments reported to CMS, 2019-2025
15 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $856 · 2022: $968 · 2023: $781 · 2024: $934 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,888.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,601.23 | 2021-2025 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $1,341.63 | 2021-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Latitude Communicator Power Supply |
| Atricure, INC. | $568.15 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Abbott Laboratories | $341.87 | 2021-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Perclose Proglide |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.45 | 2023-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $132.66 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $124.87 | 2021-2025 | Eliquis |
| Pfizer INC. | $123.15 | 2021-2023 | |
| Kestra Medical Technology Services, INC. | $80.51 | 2023-2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $69.27 | 2023-2024 | Xarelto |
| Ebr Systems, INC. | $59.12 | 2025 | |
| Merck Sharp & Dohme LLC | $39.88 | 2024-2025 | Verquvo |
| Recor Medical INC | $32.19 | 2025 | Paradise Ultrasound Renal Denervation System |
| W. L. Gore & Associates, INC. | $26.32 | 2021 | |
| Edwards Lifesciences Corporation | $17.00 | 2025 | Evoque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rodie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.